Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Proliferative Lupus Nephritis
NCT00556192Phase 2Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jun 2006
- Primary completion
- Dec 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in lupus nephritis (LN), sponsored by The Chinese University of Hong Kong. Started Jun 2006; status: completed.
02
Drugs
rituximab
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT00556192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00556192.